Alanine scanning mutagenesis of conserved arginine/lysine- arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors

Molecular Pharmacology

Volumn 50, Issue 1, 1996, Pages 140-148

  Lee, Norman H ^a   Geoghagen, Neil S M ^a   Cheng, Emily ^a   Cline, Robin T ^a   Fraser, Claire M ^a  

^a J CRAIG VENTER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC M1 RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHOLINERGIC SYSTEM; MUTAGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; SECOND MESSENGER; STRUCTURE ACTIVITY RELATION;

ALANINE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; BINDING, COMPETITIVE; CARBACHOL; CELL MEMBRANE; CHO CELLS; CONSERVED SEQUENCE; CRICETINAE; DNA PRIMERS; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; KINETICS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; N-METHYLSCOPOLAMINE; OXOTREMORINE; PROTEIN STRUCTURE, SECONDARY; QUINUCLIDINYL BENZILATE; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; RECOMBINANT PROTEINS; SCOPOLAMINE DERIVATIVES; SECOND MESSENGER SYSTEMS; TRANSFECTION;

EID: 0029953103     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Savarese, T., and C. M. Fraser. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem. J. 283:1-19 (1992).
2. Dohlman, H. G., J. Thorner, M. G. Caron, and R. J. Lefkowitz. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:653-688 (1991).
3. Fraser, C. M., N. H. Lee, S. M. Pellegrino, and A. R. Kerlavage. Molecular properties and regulation of G protein-coupled receptors. Prog. Nucl. Acid Res. 49:113-156 (1994).
4. Okamoto, T., T. Katada, Y. Murayama, M. Ui, E. Ogata, and I. Nishimoto. A simple structure encodes G protein-activating function of the IGF-II/ mannose 6-phosphate receptor. Cell 62:709-717 (1990).
5. o- Science (Washington D. C.) 362:75-79 (1993).
6. Okamoto, T., S. Takeda, Y. Murayama, E. Ogata, and I. Nishimoto. Ligand-dependent G protein coupling function of amyloid transmembrane precursor. J. Biol. Chem. 270:4205-4208 (1995).
7. 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science (Washington D. C.) 240:1310-1316 (1988).
8. Kubo, T., H. Bujo, I. Akiba, J. Nakai, M. Mishina, and S. Numa. Location of a region of the muscarinic acetylcholine receptor involved in selective effector coupling. FEBS Lett. 241:119-125 (1988).
9. Wess, J., M. R. Brann, and T. I. Bonner. Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover. FEBS Lett. 258:133-136 (1989).
10. s in response to muscarinic agonists. J. Biol. Chem. 265:6219-6224 (1990).
11. s activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell 67:723-730 (1991).
12. Luttrell, L. M., J. Ostrowski, S. Cotecchia, H. Kendall, and R. J. Lefkowitz. Antagonism of catecholamine receptor signaling by expression of cytoplasmic domains of the receptors. Science (Washington D. C.) 259:1453-1457 (1993).
13. Hawes, B. E., L. M. Luttrell, S. T. Exum, and R. J. Lefkowitz. Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J. Biol. Chem. 269:15776-15785 (1994).
14. Rens-Domiano, S., and H. E. Hamm. Structural and functional relationships of heterotrimeric G proteins. FASEB J. 9:1059-1066 (1995).
15. Wess, J. Molecular basis of muscarinic acetylcholine receptor function. Trends Pharmacol. Sci. 14:308-313 (1993).
16. Fraser, C. M., C.-D. Wang, D. A. Robinson, J. D. Gocayne, and J. C. Venter. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol. Pharmacol. 36:840-847 (1989).
17. 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol. Pharmacol. 40:168-179 (1991).
18. Franke, R. R., T. P. Sakmar, R. J. M. Graham, and H. G. Khorana. Structure and function in rhodopsin: studies of the interaction between the rhodopsin cytoplasmic domain and transducin. J Biol. Chem. 267:14767-14774 (1992).
19. Zhu, S. Z., S. Z. Wang, J. Hu, and E. E. El-Fakahany. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. Mol. Pharmacol. 45:517-523 (1994).
20. Moro, O., J. Lameh, P. Hogger, and W. Sadee. Hydrophobic amino acid in the i-2 loop plays a key role in receptor-G protein coupling. J. Biol. Chem. 268:22273-22276 (1993).
21. Bluml, K., E. Mutschler, and J. Wess. Functional role of a cytoplasmic aromatic amino acid in muscarinic receptor-mediated activation of phospholipase C. J. Biol. Chem. 269:11537-11541 (1994).
22. Burnstein, E. S., T. A. Spalding, D. Hill-Eubanks, and M. R. Brann. Structure-function of muscarinic receptor coupling to G proteins: random saturation mutagenesis identifies a critical determinant of receptor affinity for G proteins. J. Biol. Chem. 270:3141-314 (1995).
23. s by synthetic peptides corresponding to an intracellular loop of the β-adrenergic receptor. FEBS Lett. 279:277-280 (1991).
24. 2-adrenergic receptors based upon characteristics in primary structure. J. Biol. Chem. 267:8342-8346 (1992).
25. Arden, J. R., O. Nagata, M. S. Shockley, M. Philip, J. Lameh, and W. Sadee. Mutational analysis of third cytoplasmic loop domains in G protein coupling of the Hm1 muscarinic receptor. Biochem. Biophys. Res. Commun. 188:1111-1115 (1992).
26. Shapiro, R. A., D. Palmer, and T. Cislo. A deletion mutation in the third cytoplasmic loop of the mouse m1 muscarinic acetylcholine receptor unmasks cryptic G protein binding sites. J. Biol. Chem. 268:21734-21738 (1993).
27. Kunkel, M. T., and E. G. Peralta. Charged amino acids required for signal transduction by the m3 muscarinic acetylcholine receptor. EMBO J. 12: 3809-3815 (1993).
28. Hogger, P., M. S. Shockley, J. Lameh, and W. Sadee. Activating and inactivating mutations in N- and C-terminal i-3 loop junctions of muscarinic acetylcholine Hm1 receptors. J. Biol. Chem. 270:7405-7410 (1995).
29. Deng, W. P., and J. A. Nickoloff. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:81-88 (1992).
30. Lee, N. H., S. M. Pellegrino, and C. M. Fraser. Site-directed mutagenesis of α-adrenergic receptors. Neuroprotocols. 4:20-31 (1994).
31. 2-adrenergic receptors: cAMP and the third intracellular loop of m1 muscarinic receptors confer heterologous regulation. J. Biol. Chem. 268:7949-7957 (1993).
32. Lee, N. H., J. Earle-Hughes, and C. M. Fraser. Agonist-mediated destabilization of m1 muscarinic acetylcholine receptor mRNA: elements involved in mRNA stability are localized in the 3′-untranslated region. J. Biol. Chem. 269:4291-4298 (1994).
33. Savarese, T., C.-D. Wang, and C. M. Fraser. Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor: role of conserved cysteines in receptor function. J. Biol. Chem. 267:11439-11448 (1992).
34. Shapiro, R. A., and N. M. Nathanson. Deletion analysis of the mouse m1 muscarinic acetylcholine receptor: effects on phosphoinositide metabolism and down-regulation. Biochemistry 28:8946-8950 (1989).
35. Lameh, J., M. Philip, Y. K. Sharma, O. Moro, J. Ramachandran, and W. Sadee. Hm1 muscarinic cholinergic receptor internalization requires a domain in the third cytoplasmic loop. J. Biol. Chem. 267:13406-13412 (1992).
36. Buck, M. A., and C. M. Fraser. Muscarinic acetylcholine receptor subtypes which selectively couple to phospholipase C: pharmacological and biochemical properties. Biochem. Biophys. Res. Commun. 173:666-672 (1990).
37. 3H]quinuclidinyl benzilate binding sites in rat cerebral cortex homogenates. Eur. J. Pharmacol. 130:153-155 (1986).
38. Lefkowitz, R. J., S. Cotecchia, P. Samama, and T. Costa. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14:303-307 (1993).
39. Chung, F.-Z., C.-D. Wang, P. C. Potter, J. C. Venter, and C. M. Fraser. Site-directed mutagenesis and continuous expression of human β-adrenergic receptors: identification of a conserved aspartate residue involved in agonist binding and receptor activation. J. Biol. Chem. 263:4052-4055 (1988).
40. s and increase agonist affinity. J. Biol. Chem. 262:16439-16443 (1987).
41. s. J. Biol. Chem. 265:1388-1393 (1990).
42. Fisher, S. K., J. C. Figueiredo, and R. T. Bartus. Differential stimulation of inositol phospholipid turnover in brain by analogs of oxotremorine. J. Neurochem. 43:1171-1179 (1984).
43. q/11 by the m3 muscarinic acetylcholine receptor. J. Biol. Chem. 270:17741-17748 (1995).
44. Gurwitz, D., R. Haring, E. Heldman, C. M. Fraser, D. Manor, and A. Fisher. Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands. Eur. J. Pharmacol. 267:21-31 (1994).
45. Sandmann, J., E. G. Peralta, and R. J. Wurtman. Coupling of transfected muscarinic acetylcholine receptor subtypes to phospholipase D. J. Biol. Chem. 266:6031-6034 (1991).
46. Crespo, P., N. Xu, W. F. Simonds, and J. S. Gutkind. Ras-dependent activation of MAP kinase pathway mediated by G protein βγ subunits. Nature (Lond.) 369:418-4420 (1994).
47. Kennelly, P. J., and E. G. Krebs. Consensus sequences as substrate specificity determinants for protein kinases and protein phophatases. J. Biol. Chem. 266:15555-1558 (1991).
48. Haga, T., K. Haga, K Kameyama, and H. Tsuga. Phosphorylation and sequestration of muscarinic receptors, in Molecular Mechanisms of Muscarinic Acetylcholine Receptor Function (J. Wess, ed.). R. G. Landes Co., Austin, TX, 227-245 (1995).